{"disease":{"id":"bk-virus-infection","name":"bk virus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07393594","title":"ID-ENTITY Trial- Evaluating Serial T-ID Monitoring","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Transplant Genomics, Inc.","has_results":false},{"nct_id":"NCT05305040","title":"Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":451,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT01353339","title":"Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":true},{"nct_id":"NCT05264259","title":"New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT03532971","title":"Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT07347769","title":"Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT02479698","title":"Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04390113","title":"Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":97,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT06219616","title":"Prediction of BK Virus Reactivation in Kidney Transplant Recipient","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"King Chulalongkorn Memorial Hospital","has_results":false},{"nct_id":"NCT04605484","title":"Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT05026021","title":"Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia","phase":"","overall_status":"UNKNOWN","enrollment_count":41,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05101213","title":"Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04294472","title":"A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Vera Therapeutics, Inc.","has_results":true},{"nct_id":"NCT04693637","title":"Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT07503561","title":"A Study to Understand How a New, Unlicensed Drug Works, Compared With a Placebo, Against BK Virus in Patients Who Have Had a Kidney Transplant.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"AiCuris Anti-infective Cures AG","has_results":false},{"nct_id":"NCT03576014","title":"Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"SL VAXiGEN","has_results":false},{"nct_id":"NCT05042076","title":"BK With VST for Kidney Transplant Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT05511779","title":"Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"SymBio Pharmaceuticals","has_results":false},{"nct_id":"NCT07104591","title":"TETRAVI Expanded Access Program","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}